These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 5210841)
1. Interpretation of diffusion susceptibility data obtained with 50-mu g carbenicillin discs against gram-negative organisms. Traub WH; Raymond EA Appl Microbiol; 1971 Nov; 22(5):862-4. PubMed ID: 5210841 [TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Pseudomonas aeruginosa to carbenicillin. Traub WH; Raymond EA Appl Microbiol; 1970 Oct; 20(4):630-2. PubMed ID: 5498614 [TBL] [Abstract][Full Text] [Related]
3. Comparison and evaluation of ticarcillin and carbenicillin using disk diffusion methods. Parry MF; Neu HC Antimicrob Agents Chemother; 1976 Apr; 9(4):625-32. PubMed ID: 817662 [TBL] [Abstract][Full Text] [Related]
4. Antibacterial activity of apalcillin (PC-904) against gram-negative bacilli, especially ampicillin-, carbenicillin-, and gentamicin-resistant clinical isolates. Noguchi H; Kubo M; Kurashige S; Mitsuhashi S Antimicrob Agents Chemother; 1978 May; 13(5):745-52. PubMed ID: 248269 [TBL] [Abstract][Full Text] [Related]
5. Agar disk diffusion susceptibility characteristics of azlocillin, carbenicillin, mezlocillin, piperacillin, and ticarcillin. Phaneuf D; Neu HC Antimicrob Agents Chemother; 1979 Nov; 16(5):625-30. PubMed ID: 118706 [TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of gram-negative bacilli to carbenicillin. Washington JA Mayo Clin Proc; 1972 May; 47(5):332-4. PubMed ID: 4555345 [No Abstract] [Full Text] [Related]
7. Disk diffusion and serial dilution tests of susceptibility of some pathogenic gram-negative bacilli and enterococci to carbenicillin and ampicillin. Garner C; Rosner B; Finland M Antimicrob Agents Chemother; 1975 Aug; 8(2):172-86. PubMed ID: 810078 [TBL] [Abstract][Full Text] [Related]
8. [Apalcillin: in vitro activity compared with that of carbenicillin, ticarcillin, mezlocillin, piperacillin against Enterobacteriaceae and Acinetobacter]. Quentin C; Sageaux JC; Bebear C; Latrille J Pathol Biol (Paris); 1983 Jun; 31(6):463-6. PubMed ID: 6224123 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of two standardized disk methods for testing antimicrobial susceptibility of Pseudomonas aeruginosa and of the Enterobacteriaceae. Barry AL; Effinger LJ Antimicrob Agents Chemother; 1974 Oct; 6(4):452-9. PubMed ID: 4157344 [TBL] [Abstract][Full Text] [Related]
10. Susceptibility of the anaerobic bacteria, group D streptococci, Enterobacteriaceae, and Pseudomonas to semisynthetic penicillins: carbenicillin, piperacillin, and ticarcillin. Monif GR; Clark PR; Shuster JJ; Baer H Antimicrob Agents Chemother; 1978 Nov; 14(5):643-9. PubMed ID: 103491 [TBL] [Abstract][Full Text] [Related]
11. Susceptibility of Pseudomonas aeruginosa to gentamicin sulfate in vitro: lack of correlation between disc diffusion and broth dilution sensitivity data. Traub WH Appl Microbiol; 1970 Jul; 20(1):98-102. PubMed ID: 4989673 [TBL] [Abstract][Full Text] [Related]
12. In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin, and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae. Shah PP; Briedis DJ; Robson HG; Conterato JP Antimicrob Agents Chemother; 1979 Mar; 15(3):346-50. PubMed ID: 111609 [TBL] [Abstract][Full Text] [Related]
13. In vitro activity of carbenicillin against Pseudomonas using the disc diffusion method. Washington JA; Hall MM; Fausch CJ; Brackin KL Mayo Clin Proc; 1973 Oct; 48(10):718-21. PubMed ID: 4200876 [No Abstract] [Full Text] [Related]
14. In vitro studies of alpha-carboxyl-3-thienylmethyl penicillin, a new semisynthetic penicillin. Bodey GP; Deerhake B Appl Microbiol; 1971 Jan; 21(1):61-5. PubMed ID: 4924999 [TBL] [Abstract][Full Text] [Related]
15. Inter- and intralaboratory variability in antibiotic susceptibility tests with Pseudomonas aeruginosa and Enterobacteriaceae. Barry AL; Schoenknecht FD; Norton R; O'Brien TF; Matsen JM; Thornsberry C; Thrupp LD; Markley E; Gavan TL J Infect Dis; 1976 Oct; 134(4):328-35. PubMed ID: 185302 [TBL] [Abstract][Full Text] [Related]
16. Ticarcillin: a collaborative in vitro comparison with carbenicillin against over 9,000 clinical bacterial isolates. Fuchs PC; Gavan TL; Gerlach EH; Jones RN; Barry AL; Thornsberry C Am J Med Sci; 1977; 274(3):255-63. PubMed ID: 610415 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of the carbenicillin-gentamicin combination against gram-negative bacilli. Klastersky J; Swings G; Daneau D Am J Med Sci; 1970 Dec; 260(6):373-80. PubMed ID: 4997207 [No Abstract] [Full Text] [Related]
18. Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination. Felegie TP; Yu VL; Rumans LW; Yee RB Antimicrob Agents Chemother; 1979 Dec; 16(6):833-7. PubMed ID: 533264 [TBL] [Abstract][Full Text] [Related]
19. Amoxicillin: in vitro susceptibility of "blood culture strains" of gram-negative bacilli and comparisons with penicillin G ampicillin, and carbenicillin. Finland M; McGowan JE; Garner C; Wilcox C J Infect Dis; 1974 Jun; 129(0):suppl:S132-8. PubMed ID: 4210005 [No Abstract] [Full Text] [Related]
20. Semisynthetic penicillin 6-(D(--)-alpha-carboxy-3-thienylacetamido) penicillanic acid active against Pseudomonas in vitro. Neu HC; Winshell EB Appl Microbiol; 1971 Jan; 21(1):66-70. PubMed ID: 4993233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]